Successful Imatinib Treatment for Systemic Mastocytosis Associated With Myelodysplastic/Myeloproliferative Neoplasm: Report of a Case and Literature Review

Successful Imatinib Treatment for Systemic Mastocytosis Associated With Myelodysplastic/Myeloproliferative Neoplasm: Report of a Case and Literature Review

Systemic mastocytosis (SM) is a heterogeneous disease characterized by the expansion of mast cells in one or more tissues, frequently characterized by the presence of KITD816V mutation. The updated World Health Organization (WHO) classification of myeloid neoplasms recognizes SM with an associated h...

Full description

Bibliographic Details
Main Authors: Enrico Barozzi, Cristina Bucelli, Federica Irene Grifoni, Umberto Gianelli, Alessandra Iurlo, Daniele Cattaneo
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Oncology
Subjects:
imatinib
systemic mastocytosis
SM-AHN
MDS/MPN
myeloid neoplasms
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.819097/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.819097/full

Similar Items